Cornell biomedical engineers have developed specialized white blood cells – dubbed "super natural killer cells" – that seek out cancer cells in lymph nodes with only one purpose: destroy them.
It's not discrimination, but rather differences in resources attributable to career and family-related choices that set women back in science fields, Cornell researchers say. (Feb. 7, 2011)
College of Veterinary Medicine professor Dr. Robin Radcliffe is raising local awareness of two vanishing rhino species in Indonesia via a book for Indonesian children, “The Hornless Rhinoceros."
The key to curing multiple sclerosis may well lie in the mysterious signaling of lipids, a major component of cells, says Cornell chemist Jeremy Baskin.
Three pairs of early career scientists have been named the inaugural Mong Family Foundation Fellows in Neurotech. They will work jointly under the mentorship of faculty across Cornell to advance brain technologies.
To advance a powerful cancer treatment strategy that uses immune cells to fight the disease, Ellen and Gary Davis '76 have made a $2 million gift to Weill Cornell Medicine to drive ongoing research in immunotherapy.
With a $7.5 million gift from the Friedman Family Foundation, Weill Cornell Medicine has established a cross-campus center dedicated to improving human health through research in the complex relationship between nutrition, inflammation and the development of disease.
Boyce Thompson Institute are working to apply a method that boosts beta-carotene into in potatoes to cassava plants. Biofortified cassava could help alleviate vitamin A deficiency in children.
In the war against MRSA, constructing single-patient rooms – rather than sick-bay style, multi-patient rooms – reduces hospital-acquired infections among patients, says new Cornell-led study.
Dr. Arjun Srinivasan of the CDC delivered the keynote lecture at the symposium, "Antimicrobial Resistance: Research Synergies in Human and Animal Medicine," on Cornell's Ithaca campus May 4.